Atlant Clinical Completes an International, Multicenter, Double-Blind, Placebo-Controlled Clinical Trial in Patients with Prostate Cancer

Atlant Clinical has successfully completed an international, multicenter, double-blind, placebo-controlled, Phase IIIa study in patients with prostate cancer.
Source: Pharmaceutical Technology - Category: Pharmaceuticals Source Type: news